CoChat

De novo depression and anxiety disorders and influence on adherence during peginterferon‐alpha‐2a and ribavirin treatment in patients with hepatitis C

Open access
MARTÍN‐SANTOS, R., DÍEZ‐QUEVEDO, C., CASTELLVÍ, P., NAVINÉS, R., MIQUEL, M., MASNOU, H., SOLER, A., ARDEVOL, M., GARCÍA, F., GALERAS, J. A., PLANAS, R., SOLÀ, R. · 2008 · Alimentary Pharmacology & Therapeutics
Cited by 79

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Summary: Background Depression and anxiety have been associated with interferon treatment and low treatment adherence. Aim To study the incidence and associated risk factors of depressive and anxiety disorders during pegylated interferon plus ribavirin and treatment adherence in a prospective cohort of 176 patients with chronic hepatitis C patients. Methods Patients were interviewed at baseline using the Structured Clinical Interview for DSM‐IV Mental Disorders and the Patient Health Questionnaire and the Hospital Anxiety and Depression Scale were completed. Both questionnaires were completed also after 4, 12 and 24 weeks of treatment. Results De novo depressive and/or anxiety disorders were diagnosed in 53 (36%) patients, in whom antidepressants and/or anxiolytics were administered. Higher baseline depression‐subscale score (OR = 27.8, 95% CI = 2.82–333), primary education level (OR = 3.1, 95% CI = 1.40–7.03) and being an immigrant (OR = 3.2, 95% CI = 1.12–9.47) were predictors of psychiatric disorders during anti‐viral therapy. The percentage of patients with good adherence was lower in those with depression and/or anxiety (79% vs. 90%, P < 0.04). Only one patient (1%) discontinued treatment because of a major depressive episode. Depression and/or anxiety disorders had no effect on attainment of sustained virological response. Conclusion Early detection and treatment of depressive and anxiety disorders favours good adherence to anti‐viral treatment in hepatitis C.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2007.03568.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 79

Metadata

Authors
MARTÍN‐SANTOS, R., DÍEZ‐QUEVEDO, C., CASTELLVÍ, P., NAVINÉS, R., MIQUEL, M., MASNOU, H., SOLER, A., ARDEVOL, M., GARCÍA, F., GALERAS, J. A., PLANAS, R., & SOLÀ, R.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2007-11-06
Volume
27
Issue
3
Pages
257-265
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1925910633
Cited by
79
References
7
FWCI
2.43
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: De novo depression and anxiety disorders and influence on adherence during peginterferon‐alpha‐2a and ribavirin treatment in patients with hepatitis C. https://app.cochat.ai/papers/10.1111/j.1365-2036.2007.03568.x
The paper
MARTÍN‐SANTOS, R., DÍEZ‐QUEVEDO, C., CASTELLVÍ, P., NAVINÉS, R., MIQUEL, M., MASNOU, H., SOLER, A., ARDEVOL, M., GARCÍA, F., GALERAS, J. A., PLANAS, R., & SOLÀ, R. (2008). De novo depression and anxiety disorders and influence on adherence during peginterferon‐alpha‐2a and ribavirin treatment in patients with hepatitis C. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2007.03568.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.